Medical-device announcements often lead with a regulatory milestone. A product has received FDA clearance, gained approval or been registered with the agency. For someone researching the product, the useful question is which record supports that description.

Clearance and approval describe different FDA review pathways. Registration has a separate administrative role. Knowing which term applies helps buyers, analysts and business teams locate the right documents and describe the product accurately.

What FDA clearance means

A 510(k) submission asks the FDA to determine whether a device is substantially equivalent to a legally marketed device that is not subject to premarket approval. That comparison considers intended use and technological characteristics, with supporting information used to address the relevant questions of safety and effectiveness.

A device found substantially equivalent through this pathway is commonly described as FDA cleared. Researchers can use the 510(k) number to find the applicant, device name, decision date and available supporting documents. The FDA’s overview explains that some devices are exempt from 510(k) requirements.

What FDA approval means

Premarket approval, or PMA, is a different application pathway. The FDA describes PMA review as being based on scientific evidence sufficient to provide reasonable assurance of a device’s safety and effectiveness for its intended uses.

When investigating a PMA announcement, look for the original application and any relevant supplements. The record should help establish which device and decision the announcement concerns. Retaining the application identifier makes a brief or comparison easier for colleagues to check.

The FDA also describes other routes, including De Novo classification for certain novel devices of low to moderate risk. A product’s regulatory history should be described using the pathway it actually followed.

Why registration is different

The establishment registration and device listing system contains information about registered manufacturers and listed devices. The FDA explicitly states that registration, assignment of a registration number or device listing does not denote approval of the establishment or its products.

If a supplier provides a registration number, ask which product-specific record or applicable exemption explains the device’s route to market. Keep those pieces of information separate in your notes. They have different meanings even when they appear in the same sales document.

Match the record to the product

Begin with the submission identifier and named applicant. Then compare the product name and available model information with the product being discussed. A unique device identifier can provide another way to identify the labeler and a specific version or model; it has a different role from a premarket submission number.

For an internal report, record the pathway, identifier, date and source link together. Describe the milestone using the wording supported by the decision. If the announcement concerns a supplement or a particular product configuration, make that scope clear in the report.

Questions to ask after an announcement

Ask the company for the decision document, the associated labeling and the exact product or version covered. For a commercial assessment, also ask about availability, implementation and support. These are separate questions that a regulatory milestone alone will not answer.

The result is a more useful company or product brief: readers can see what happened, which technology it concerns and where to examine the supporting record.